Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening ...

BYD officially marked its entry into the Swiss market by hosting a brand launch event from April 1 to 2, unveiling its first wave of models to local consumers.